RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 98 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | -40.0% | 251 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | -99.7% | 251 | -99.7% | 0.00% | -100.0% |
Q2 2020 | $1,926,000 | +217.3% | 86,359 | +116.7% | 0.01% | +200.0% |
Q1 2020 | $607,000 | – | 39,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 2,981,437 | $86,969,000 | 72.32% |
MPM ASSET MANAGEMENT LLC | 3,074,893 | $89,695,000 | 60.73% |
Foresite Capital Management IV, LLC | 696,903 | $20,329,000 | 6.66% |
NEA Management Company, LLC | 4,912,306 | $143,292,000 | 6.18% |
RA Capital Management | 1,950,332 | $56,891,000 | 3.04% |
Trustees of Princeton University | 47,643 | $1,390,000 | 1.96% |
Greylock XII GP LLC | 54,749 | $1,597,000 | 1.12% |
Baker Brothers Advisors | 2,708,200 | $78,998,000 | 0.52% |
Perceptive Advisors | 664,186 | $19,374,000 | 0.52% |
Sofinnova Investments, Inc. | 159,302 | $4,646,000 | 0.41% |